Developer docs
API playgroundTry for free, no card

Search company profiles

Hardy Diagnostics

Full company profile

uuid0008jbm

Namestring
Hardy Diagnostics
Legal namestring
Hardy Diagnostics
Company typeenum
Private
Founded yearint
1980
Descriptiontext

Hardy Diagnostics is a 46-year-old, 100% employee-owned US manufacturer and distributor of microbiological products headquartered in Santa Maria, California. The company manufactures over 2,700 products in-house — spanning prepared and dehydrated culture media (CRITERION, HardyCHROM chromogenic media, CompactDry ready-to-use plates), rapid diagnostic lateral flow assays (the NG-TEST portfolio distributed from NG Biotech), antimicrobial susceptibility disks (HardyDisks, MASTDISCS), environmental monitoring instruments (TRIO.BAS air samplers, EnSURE ATP systems), specimen collection systems (HealthLink, TransPRO VTM), and adjunct laboratory equipment — and distributes over 13,000 laboratory products in total. It operates as an FDA-licensed in vitro medical device manufacturer under ISO 13485 and ISO 17025 certifications, with products supporting USP <60>-<800> compliance, AOAC/MicroVal/NordValid approvals, and FDA Breakthrough Device Designations for NG-TEST Candida auris and Acineto-5.

The company serves five primary end-markets: clinical diagnostics (hospitals, reference labs, physician offices), pharmaceutical and compounding pharmacy microbiology (sterility, environmental monitoring, USP compliance), food and beverage safety testing, cannabis quality assurance, and cosmetics testing. Revenue is generated through catalog unit-pricing on a transactional e-commerce storefront, direct enterprise sales supported by a dedicated sales representative network, GSA Advantage government procurement contracts, custom product development and contract manufacturing, and exclusive US distribution arrangements for partner brands (NG Biotech, NEMIS Technologies, Gradientech, Hygiena, Microbiologics, Sartorius).

Distribution is conducted through 10 US distribution centers enabling next-day delivery, with no disclosed international manufacturing footprint. The founder Jay Hardy retired as President and CEO in October 2025 after 45+ years and was succeeded by Christopher Catani. Named enterprise customers include Pepsi, Procter &amp; Gamble, and Thermo Fisher Scientific.

Short descriptiontext

Hardy Diagnostics is a 100% employee-owned US manufacturer and distributor of microbiological products serving clinical, pharmaceutical, food safety, cannabis, and cosmetics laboratories with over 13,000 SKUs through 10 US distribution centers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersSanta Maria, United States
HQ citystring
Santa Maria
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microbiological culture media, clinical diagnostics products, rapid pathogen detection, food safety testing, pharmaceutical microbiology supplies
Industry2 codes
1Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)
CodeHLAAALACPrimaryYes
2Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility)
CodeHLAGADAEPrimaryNo
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Surgical & Medical Instruments & Apparatus3841
Product category
Microbiology Laboratory Products and Diagnostics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Microbiology Products Sales
TypeOne Time License
Description

Hardy Diagnostics generates revenue through the manufacture and sale of microbiology products including prepared culture media, dehydrated culture media, rapid detection kits, instruments, reagents, and laboratory supplies. The company manufactures over 2,700 products in-house and distributes over 13,000 laboratory products total.

hardydiagnostics.com
2Custom Product Development
TypeProfessional Services
Description

The company offers custom product development and contract manufacturing services for unique culture media formulas and testing solutions tailored to customer specifications.

hardydiagnostics.com
3Distribution Services
TypeTransaction Fee
Description

Distribution of third-party microbiology products alongside proprietary products through 10 distribution centers across the US.

hardydiagnostics.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Standard product catalog pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Individual product pricing based on quantity and package size. Products available for direct purchase through website with account creation.

hardydiagnostics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 21 records shown
1HardyCHROM™
Description

Chromogenic culture media brand for differential identification of microorganisms including Candida species, CRE, MRSA, Salmonella, Shigella, and other pathogens.

hardydiagnostics.com
+20 more records
Core offering1 text field

Hardy Diagnostics manufactures and distributes microbiological products for clinical, pharmaceutical, food and beverage, cannabis, and cosmetics laboratories. Its portfolio of more than 13,000 laboratory products (over 2,700 manufactured in-house) includes culture media, rapid diagnostic assays, antimicrobial susceptibility disks, specimen collection devices, and laboratory instruments. The company also offers custom product development, contract manufacturing, regulatory submission support, and instrument services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Strep B Carrot Broth demonstrated 98.8% sensitivity and 98.2% specificity for Group B Streptococcus detection compared to LIM Broth
+2 more records
Product overview1 text field

Hardy Diagnostics is a microbiology products manufacturer and distributor offering over 13,000 laboratory products with 2,700 manufactured in-house. The portfolio is organized around core platform capabilities including culture media (CRITERION™ dehydrated media, HardyCHROM™ chromogenic media, CompactDry™ ready-to-use plates), rapid diagnostics (NG-TEST® lateral flow assays for CARBA 5, Candida auris, CTX-M, distributed from NG Biotech), susceptibility testing (HardyDisks™, MASTDISCS®, HardyDisk™ AST), environmental monitoring (TRIO.BAS™ air samplers, EnSURE™ ATP systems), and sample collection (HealthLink®, TransPRO™ VTM, LABPLAS). Key differentiated products include Strep B Carrot Broth™ One-Step with 98.8% sensitivity, HardyCHROM™ Candida + auris chromogenic medium with UV fluorescence, and proprietary AnaeroGRO™ anaerobic products. The company operates as exclusive US distributor for multiple partner brands including NG Biotech, NEMIS Technologies (N-Light™), Microbiologics®, and Hygiena® (EnSURE™). Products serve clinical diagnostics, pharmaceutical microbiology (USP compliance), food safety testing, cannabis QA, and cosmetics testing markets.

Product and service32 records
1HardyCHROM Chromogenic Culture Media
CategoryCulture Media
Description

Chromogenic culture media for differential identification of microorganisms including Candida species, CRE, ESBL, MRSA, Salmonella, Shigella, Group A Strep, UTI, and Vibrio based on color reactions, with fluorescence detection for Candida auris.

2CRITERION Dehydrated Culture Media
CategoryCulture Media
Description

Dehydrated culture media for preparation of agar plates and broths in laboratory settings across clinical, pharmaceutical, and food safety applications.

3CompactDry Ready-to-Use Culture Plates
CategoryCulture Media
Description

Ready-to-use dehydrated culture media plates for quantitative microbial testing including total count and organism-specific tests for environmental monitoring and finished goods testing, with 18-month room-temperature shelf life and AOAC, MicroVal, and NordVal approval.

4HardyDisks Antimicrobial Susceptibility Testing Disks
CategorySusceptibility Testing
Description

Antimicrobial susceptibility testing disks for Kirby-Bauer disk diffusion method to determine in vitro susceptibility of bacteria and fungi to various antimicrobial compounds.

5AnaeroGRO Anaerobic Bacteriology Products
CategoryCulture Media
Description

Anaerobic bacteriology products including multiPak plates, Brucella media with H&K supplements, PEA plates, and BBE/LKV biplates for cultivation of anaerobic microorganisms.

6TRIO.BAS Continuous Air Monitoring System
CategoryEnvironmental Monitoring Instruments
Description

Continuous air monitoring instruments for viable particulates in clean room and pharmaceutical environments, supporting Annex 1 compliance requirements.

7HealthLink Specimen Collection and Transport Products
CategorySpecimen Collection
Description

Swabs and specimen collection products for collection and transport of clinical specimens including viral transport medium for Influenza, Adenovirus, and Echovirus.

8TransPRO Viral Transport Medium System
CategorySpecimen Collection
Description

Viral transport medium system with sterile wrapped NP swab for collection and transport of clinical specimens, room temperature stable and containing antibiotics and antifungal agents.

9Strep B Carrot Broth One-Step
CategoryRapid Diagnostics
Description

Chromogenic broth for cultivation and identification of Group B Streptococcus in pregnant women, providing results in as few as 8 hours with 98.8% sensitivity and 98.2% specificity.

10NG-TEST CARBA 5
CategoryRapid Diagnostics
Description

Lateral flow immunoassay for detection of five bacterial carbapenemase enzymes (KPC, NDM, OXA-48-like, VIM, IMP) directly from bacterial colonies within minutes.

11NG-TEST Candida auris Rapid Diagnostic
CategoryRapid Diagnostics
Description

Rapid lateral flow immunoassay for detection of Candida auris multidrug-resistant yeast, delivering results in 15 minutes without requiring PCR or specialized equipment.

12NG-TEST Acineto-5 Rapid Diagnostic
CategoryRapid Diagnostics
Description

Rapid diagnostic assay for detection of Acinetobacter species and drug-resistant strains, delivering results in 15 minutes using lateral flow immunoassay technology.

13NG-TEST CTX-M Multi
CategoryRapid Diagnostics
Description

Lateral flow immunoassay for detection of CTX-M extended-spectrum beta-lactamase enzymes, addressing the rising prevalence of ESBL-producing bacteria in North America.

14QwikID Lateral Flow Assays
CategoryRapid Diagnostics
Description

Lateral flow assays for rapid organism identification, including StrepQuick PYR test kit for identification of Enterococcus and Group A Streptococcus.

15MALDI-TOF Mass Spectrometry System (ms1000)
CategoryIdentification Instruments
Description

Automated MALDI-TOF mass spectrometry system for rapid identification of bacteria, yeasts, fungi, and filamentous fungi based on proteomic fingerprinting.

16NEMIS N-Light Rapid On-Site Pathogen Detection
CategoryRapid Diagnostics
Description

Chemiluminescence-based rapid on-site pathogen detection system from NEMIS Technologies distributed exclusively in North America by Hardy Diagnostics for food manufacturers and environmental testing teams.

17EnSURE ATP Hygiene Monitoring System
CategoryEnvironmental Monitoring
Description

ATP-based hygiene monitoring system for surface and environmental sampling, used with UltraSnap sample collection devices and Hygiena luminometers.

18UltraSnap ATP Sampling Device
CategoryEnvironmental Monitoring
Description

All-in-one pen-sized ATP sampling device with liquid-stable reagent, used with Hygiena luminometers for hygiene verification.

19Microbiologics Quality Control Organisms
CategoryQuality Control
Description

Quality control microorganisms and reference organisms for validation and verification of microbiological testing procedures, distributed from Microbiologics.

20StrepPRO Streptococcal Grouping Kit
CategoryRapid Identification Reagents
Description

Latex agglutination kit for serological identification of Lancefield streptococcal groups A, B, C, D, F, and G from isolated colonies.

21CoaguStaph Rabbit Coagulase Plasma
CategoryRapid Identification Reagents
Description

Rabbit coagulase plasma for identification of Staphylococcus aureus, available in freeze-dried and ready-to-use cryovial formats.

22HardyCHROM Candida + auris Chromogenic Medium
CategoryCulture Media
Description

Chromogenic medium for selective isolation and differential identification of Candida species including C. auris, with C. auris colonies appearing white with teal-green bullseye center under UV light fluorescence.

23Dilugent Shaker Serial-Dilution Instrument
CategoryLaboratory Instruments
Description

Semi-automated serial-dilution instrument offering improvements over traditional serial dilution workflow for food safety testing.

24Gram Stain Kit Advanced
CategoryStaining Reagents
Description

Gram staining kit with stabilized iodine for bacterial classification in clinical microbiology.

25ImmuView Urinary Antigen Test
CategoryRapid Diagnostics
Description

Urinary antigen test for detection of Streptococcus pneumoniae and Legionella pneumophila.

26HardyDisk AST Aztreonam-Avibactam
CategorySusceptibility Testing
Description

Antimicrobial susceptibility testing disk for the Aztreonam-Avibactam combination used against carbapenem-resistant infections.

27MASTDISCS Cartridge Discs
CategorySusceptibility Testing
Description

Cartridge discs for antimicrobial susceptibility diffusion testing including Cefoperazone, Cefovecin, Cefquinome, Florfenicol, Gamithromycin, Marbofloxacin, Mupirocin, Neomycin, and Orbifloxacin.

28LABPLAS Whirl-Pak Sampling Bags
CategorySample Collection
Description

Whirl-Pak sampling bags and environmental monitoring products for food safety testing.

29HardyVAL Media Fill Challenge Testing System
CategoryPharmaceutical Compliance Testing
Description

Media fill challenge testing solution for USP 797 compounding pharmacy compliance that simulates aseptic manipulation for competency evaluations.

30Custom Product Development and Contract Manufacturing
CategoryProfessional Services
Description

Custom product development and contract manufacturing service for unique culture media formulas and testing solutions tailored to customer specifications.

31Product Evaluations and Regulatory Submission Services
CategoryProfessional Services
Description

Product evaluation and regulatory submission services including 510(k) and AOAC certification support for microbiology products.

32Instrument Services
CategoryProfessional Services
Description

Equipment service and support for laboratory instruments purchased through Hardy Diagnostics.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-18
Description

Hardy Diagnostics partnered with NG Biotech to develop and distribute rapid diagnostic assays NG-TEST Candida auris and NG-TEST Acineto-5. These tests received FDA Breakthrough Device Designation targeting critical drug-resistant pathogens identified by WHO. The assays deliver results in 15 minutes using lateral flow immunoassay technology without requiring PCR or specialized equipment. Hardy Diagnostics serves as the exclusive US distributor for these tests, which are currently available for Research Use Only while FDA review continues. The Candida auris test is the first rapid lateral flow immunoassay specifically designed to identify that multidrug-resistant yeast.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-12-19
Description

Hardy Diagnostics entered a strategic partnership with Swiss-based NEMIS Technologies to exclusively distribute NEMIS N-Light rapid on-site pathogen detection technology in North America. The chemiluminescence-based system enables food manufacturers and environmental testing teams to conduct rapid pathogen detection directly on-site for improved contamination control. The partnership includes educational initiatives through NEMIS Academy aimed at transforming food safety standards across the region. NEMIS's technology is already trusted by major European food producers.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-02-19
Description

Hardy Diagnostics serves as the exclusive US distribution partner for Gradientech's QuickMIC diagnostic system, which provides rapid antimicrobial susceptibility testing results within 2-4 hours. The system is currently CE marked and used in European hospitals. Gradientech submitted its 510(k) premarket notification to the FDA in late 2025, and FDA clearance would enable Hardy Diagnostics to commercialize the QuickMIC system in the United States.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Hardy Diagnostics distributes Microbiologics quality control organisms and molecular controls for use in microbiology laboratories. The partnership provides access to QC microorganisms and reference organisms for laboratory validation and testing procedures.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Hardy Diagnostics distributes Hygiena ATP monitoring systems including EnSURE luminometers and UltraSnap ATP tests for surface hygiene verification in food safety and environmental monitoring applications.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Hardy Diagnostics distributes Sartorius Sterisart sterility testing systems including membrane filtration equipment for pharmaceutical quality control and USP 71 sterility testing compliance.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Bio-Rad is a leading life science and clinical diagnostics manufacturer with a large microbiology product portfolio including culture media, immunoassays, and quality controls, directly competing with Hardy Diagnostics in clinical microbiology labs across the US.

TypeDirect peer
Description

bioMérieux is a global leader in in vitro microbiology diagnostics, including culture media (BioBall, culture plates), VITEK identification/AST systems, and industrial microbiology solutions - directly comparable to Hardy's clinical and pharma microbiology portfolio.

TypeDirect peer
Description

Neogen (now merged with 3M's Food Safety business) provides food safety diagnostics, pathogen detection kits, and laboratory products directly comparable to Hardy's food safety testing segment including CompactDry and pathogen detection assays.

TypeBroad incumbent
Description

BD is a broad medical device and diagnostics incumbent with a microbiology portfolio spanning sample collection, plated media, and identification/AST systems, overlapping with Hardy's clinical microbiology offerings as part of a much wider healthcare catalog.

TypeBroad incumbent
Description

Thermo Fisher operates a massive life sciences catalog including Remel microbiology culture media and diagnostic reagents. It is both a Hardy customer (per disclosed customer list) and a broad incumbent competitor in clinical, food, and pharma microbiology.

TypeBroad incumbent
Description

Beckman Coulter, part of Danaher, provides clinical diagnostics including microbiology automation and laboratory information systems, competing with Hardy's clinical lab offerings as part of a much broader diagnostics portfolio.

TypeDirect peer
Description

Eiken Chemical is a Japanese manufacturer specializing in chromogenic culture media, rapid diagnostics, and molecular microbiology products - directly comparable to Hardy's HardyCHROM chromogenic media franchise and compact dry plate lines.

TypeEmerging player
Description

Microbiologics is a specialty manufacturer of quality control microorganisms, reference strains, and molecular controls for clinical and food labs - a Hardy distribution partner but also a niche competitor in QC organism products.

TypeEmerging player
Description

R-Biopharm develops and distributes food and clinical pathogen detection kits, lateral flow assays, and laboratory reagents, overlapping with Hardy's food safety and rapid diagnostic offerings particularly across Europe.

TypeOthers
Description

Hygiena is a manufacturer of ATP hygiene monitoring systems (EnSURE luminometers, UltraSnap tests) - Hardy distributes Hygiena products in the US but Hygiena competes with Hardy's environmental monitoring offerings as part of a broader food safety portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hardy Diagnostics

Microbiology Laboratory Products and Diagnosticshardydiagnostics.com

Hardy Diagnostics is a 100% employee-owned US manufacturer and distributor of microbiological products serving clinical, pharmaceutical, food safety, cannabis, and cosmetics laboratories with over 13,000 SKUs through 10 US distribution centers.

What Hardy Diagnostics does

Hardy Diagnostics is a 46-year-old, 100% employee-owned US manufacturer and distributor of microbiological products headquartered in Santa Maria, California. The company manufactures over 2,700 products in-house — spanning prepared and dehydrated culture media (CRITERION, HardyCHROM chromogenic media, CompactDry ready-to-use plates), rapid diagnostic lateral flow assays (the NG-TEST portfolio distributed from NG Biotech), antimicrobial susceptibility disks (HardyDisks, MASTDISCS), environmental monitoring instruments (TRIO.BAS air samplers, EnSURE ATP systems), specimen collection systems (HealthLink, TransPRO VTM), and adjunct laboratory equipment — and distributes over 13,000 laboratory products in total. It operates as an FDA-licensed in vitro medical device manufacturer under ISO 13485 and ISO 17025 certifications, with products supporting USP <60>-<800> compliance, AOAC/MicroVal/NordValid approvals, and FDA Breakthrough Device Designations for NG-TEST Candida auris and Acineto-5.

The company serves five primary end-markets: clinical diagnostics (hospitals, reference labs, physician offices), pharmaceutical and compounding pharmacy microbiology (sterility, environmental monitoring, USP compliance), food and beverage safety testing, cannabis quality assurance, and cosmetics testing. Revenue is generated through catalog unit-pricing on a transactional e-commerce storefront, direct enterprise sales supported by a dedicated sales representative network, GSA Advantage government procurement contracts, custom product development and contract manufacturing, and exclusive US distribution arrangements for partner brands (NG Biotech, NEMIS Technologies, Gradientech, Hygiena, Microbiologics, Sartorius).

Distribution is conducted through 10 US distribution centers enabling next-day delivery, with no disclosed international manufacturing footprint. The founder Jay Hardy retired as President and CEO in October 2025 after 45+ years and was succeeded by Christopher Catani. Named enterprise customers include Pepsi, Procter &amp; Gamble, and Thermo Fisher Scientific.

Hardy Diagnostics firmographics

Firmographics
Name
Hardy Diagnostics
Legal name
Hardy Diagnostics
Website
https://hardydiagnostics.com
Company type
Private
Founded year
1980
Operating status
Operating
Headcount range
251–500 employees
Short description
Hardy Diagnostics is a 100% employee-owned US manufacturer and distributor of microbiological products serving clinical, pharmaceutical, food safety, cannabis, and cosmetics laboratories with over 13,000 SKUs through 10 US distribution centers.
Ownership category
akta.pro rank

Hardy Diagnostics industry classification

Industry
Product category
Microbiology Laboratory Products and Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)
akta.pro secondary industry
Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE)

Keywords

  • Microbiological culture media
  • Clinical diagnostics products
  • Rapid pathogen detection
  • Food safety testing
  • Pharmaceutical microbiology supplies

Where Hardy Diagnostics is headquartered

Location

Headquarters

HQ city
Santa Maria
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Hardy Diagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Microbiology Products Sales: Hardy Diagnostics generates revenue through the manufacture and sale of microbiology products including prepared culture media, dehydrated culture media, rapid detection kits, instruments, reagents, and laboratory supplies. The company manufactures over 2,700 products in-house and distributes over 13,000 laboratory products total.
  2. Custom Product Development: The company offers custom product development and contract manufacturing services for unique culture media formulas and testing solutions tailored to customer specifications.
  3. Distribution Services: Distribution of third-party microbiology products alongside proprietary products through 10 distribution centers across the US.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard product catalog pricing

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Hardy Diagnostics product offering

Product offering

Core offering

Hardy Diagnostics manufactures and distributes microbiological products for clinical, pharmaceutical, food and beverage, cannabis, and cosmetics laboratories. Its portfolio of more than 13,000 laboratory products (over 2,700 manufactured in-house) includes culture media, rapid diagnostic assays, antimicrobial susceptibility disks, specimen collection devices, and laboratory instruments. The company also offers custom product development, contract manufacturing, regulatory submission support, and instrument services.

Product overview

Hardy Diagnostics is a microbiology products manufacturer and distributor offering over 13,000 laboratory products with 2,700 manufactured in-house. The portfolio is organized around core platform capabilities including culture media (CRITERION™ dehydrated media, HardyCHROM™ chromogenic media, CompactDry™ ready-to-use plates), rapid diagnostics (NG-TEST® lateral flow assays for CARBA 5, Candida auris, CTX-M, distributed from NG Biotech), susceptibility testing (HardyDisks™, MASTDISCS®, HardyDisk™ AST), environmental monitoring (TRIO.BAS™ air samplers, EnSURE™ ATP systems), and sample collection (HealthLink®, TransPRO™ VTM, LABPLAS). Key differentiated products include Strep B Carrot Broth™ One-Step with 98.8% sensitivity, HardyCHROM™ Candida + auris chromogenic medium with UV fluorescence, and proprietary AnaeroGRO™ anaerobic products. The company operates as exclusive US distributor for multiple partner brands including NG Biotech, NEMIS Technologies (N-Light™), Microbiologics®, and Hygiena® (EnSURE™). Products serve clinical diagnostics, pharmaceutical microbiology (USP compliance), food safety testing, cannabis QA, and cosmetics testing markets.

Differentiator

Problem solved

Functional benefit

Brands

  • HardyCHROM™: Chromogenic culture media brand for differential identification of microorganisms including Candida species, CRE, MRSA, Salmonella, Shigella, and other pathogens.
  • HardyDisks™
  • HardyVAL™
  • AnaeroGRO™
  • CRITERION™
  • CompactDry™
  • CryoSavers™
  • DiluLok™
  • Dilugent®
  • DuraRack®
  • QwikID™
  • StrepQuick™
  • StrepPRO™
  • Carrot Broth™
  • CoaguStaph™
  • HardyBasix™
  • HealthLink®
  • NG-TEST®
  • EnSURE™
  • TRIO.BAS™
  • N-Light™

Products and services

  • HardyCHROM Chromogenic Culture Media Chromogenic culture media for differential identification of microorganisms including Candida species, CRE, ESBL, MRSA, Salmonella, Shigella, Group A Strep, UTI, and Vibrio based on color reactions, with fluorescence detection for Candida auris.
  • CRITERION Dehydrated Culture Media Dehydrated culture media for preparation of agar plates and broths in laboratory settings across clinical, pharmaceutical, and food safety applications.
  • CompactDry Ready-to-Use Culture Plates Ready-to-use dehydrated culture media plates for quantitative microbial testing including total count and organism-specific tests for environmental monitoring and finished goods testing, with 18-month room-temperature shelf life and AOAC, MicroVal, and NordVal approval.
  • HardyDisks Antimicrobial Susceptibility Testing Disks Antimicrobial susceptibility testing disks for Kirby-Bauer disk diffusion method to determine in vitro susceptibility of bacteria and fungi to various antimicrobial compounds.
  • AnaeroGRO Anaerobic Bacteriology Products Anaerobic bacteriology products including multiPak plates, Brucella media with H&K supplements, PEA plates, and BBE/LKV biplates for cultivation of anaerobic microorganisms.
  • TRIO.BAS Continuous Air Monitoring System Continuous air monitoring instruments for viable particulates in clean room and pharmaceutical environments, supporting Annex 1 compliance requirements.
  • HealthLink Specimen Collection and Transport Products Swabs and specimen collection products for collection and transport of clinical specimens including viral transport medium for Influenza, Adenovirus, and Echovirus.
  • TransPRO Viral Transport Medium System Viral transport medium system with sterile wrapped NP swab for collection and transport of clinical specimens, room temperature stable and containing antibiotics and antifungal agents.
  • Strep B Carrot Broth One-Step Chromogenic broth for cultivation and identification of Group B Streptococcus in pregnant women, providing results in as few as 8 hours with 98.8% sensitivity and 98.2% specificity.
  • NG-TEST CARBA 5 Lateral flow immunoassay for detection of five bacterial carbapenemase enzymes (KPC, NDM, OXA-48-like, VIM, IMP) directly from bacterial colonies within minutes.
  • NG-TEST Candida auris Rapid Diagnostic Rapid lateral flow immunoassay for detection of Candida auris multidrug-resistant yeast, delivering results in 15 minutes without requiring PCR or specialized equipment.
  • NG-TEST Acineto-5 Rapid Diagnostic Rapid diagnostic assay for detection of Acinetobacter species and drug-resistant strains, delivering results in 15 minutes using lateral flow immunoassay technology.
  • NG-TEST CTX-M Multi Lateral flow immunoassay for detection of CTX-M extended-spectrum beta-lactamase enzymes, addressing the rising prevalence of ESBL-producing bacteria in North America.
  • QwikID Lateral Flow Assays Lateral flow assays for rapid organism identification, including StrepQuick PYR test kit for identification of Enterococcus and Group A Streptococcus.
  • MALDI-TOF Mass Spectrometry System (ms1000) Automated MALDI-TOF mass spectrometry system for rapid identification of bacteria, yeasts, fungi, and filamentous fungi based on proteomic fingerprinting.
  • NEMIS N-Light Rapid On-Site Pathogen Detection Chemiluminescence-based rapid on-site pathogen detection system from NEMIS Technologies distributed exclusively in North America by Hardy Diagnostics for food manufacturers and environmental testing teams.
  • EnSURE ATP Hygiene Monitoring System ATP-based hygiene monitoring system for surface and environmental sampling, used with UltraSnap sample collection devices and Hygiena luminometers.
  • UltraSnap ATP Sampling Device All-in-one pen-sized ATP sampling device with liquid-stable reagent, used with Hygiena luminometers for hygiene verification.
  • Microbiologics Quality Control Organisms Quality control microorganisms and reference organisms for validation and verification of microbiological testing procedures, distributed from Microbiologics.
  • StrepPRO Streptococcal Grouping Kit Latex agglutination kit for serological identification of Lancefield streptococcal groups A, B, C, D, F, and G from isolated colonies.
  • CoaguStaph Rabbit Coagulase Plasma Rabbit coagulase plasma for identification of Staphylococcus aureus, available in freeze-dried and ready-to-use cryovial formats.
  • HardyCHROM Candida + auris Chromogenic Medium Chromogenic medium for selective isolation and differential identification of Candida species including C. auris, with C. auris colonies appearing white with teal-green bullseye center under UV light fluorescence.
  • Dilugent Shaker Serial-Dilution Instrument Semi-automated serial-dilution instrument offering improvements over traditional serial dilution workflow for food safety testing.
  • Gram Stain Kit Advanced Gram staining kit with stabilized iodine for bacterial classification in clinical microbiology.
  • ImmuView Urinary Antigen Test Urinary antigen test for detection of Streptococcus pneumoniae and Legionella pneumophila.
  • HardyDisk AST Aztreonam-Avibactam Antimicrobial susceptibility testing disk for the Aztreonam-Avibactam combination used against carbapenem-resistant infections.
  • MASTDISCS Cartridge Discs Cartridge discs for antimicrobial susceptibility diffusion testing including Cefoperazone, Cefovecin, Cefquinome, Florfenicol, Gamithromycin, Marbofloxacin, Mupirocin, Neomycin, and Orbifloxacin.
  • LABPLAS Whirl-Pak Sampling Bags Whirl-Pak sampling bags and environmental monitoring products for food safety testing.
  • HardyVAL Media Fill Challenge Testing System Media fill challenge testing solution for USP 797 compounding pharmacy compliance that simulates aseptic manipulation for competency evaluations.
  • Custom Product Development and Contract Manufacturing Custom product development and contract manufacturing service for unique culture media formulas and testing solutions tailored to customer specifications.
  • Product Evaluations and Regulatory Submission Services Product evaluation and regulatory submission services including 510(k) and AOAC certification support for microbiology products.
  • Instrument Services Equipment service and support for laboratory instruments purchased through Hardy Diagnostics.

Quantifiable outcome

  • Strep B Carrot Broth demonstrated 98.8% sensitivity and 98.2% specificity for Group B Streptococcus detection compared to LIM Broth
  • +2 more outcomes

Companies that use Hardy Diagnostics

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Hardy Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Hardy Diagnostics partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • NG BiotechcoreStrategic or Co-development Partner · 18 February 2026Hardy Diagnostics partnered with NG Biotech to develop and distribute rapid diagnostic assays NG-TEST Candida auris and NG-TEST Acineto-5. These tests received FDA Breakthrough Device Designation targeting critical drug-resistant pathogens identified by WHO. The assays deliver results in 15 minutes using lateral flow immunoassay technology without requiring PCR or specialized equipment. Hardy Diagnostics serves as the exclusive US distributor for these tests, which are currently available for Research Use Only while FDA review continues. The Candida auris test is the first rapid lateral flow immunoassay specifically designed to identify that multidrug-resistant yeast.
  • NEMIS TechnologiescoreChannel Partner/ Reseller/ Distributor · 19 December 2025Hardy Diagnostics entered a strategic partnership with Swiss-based NEMIS Technologies to exclusively distribute NEMIS N-Light rapid on-site pathogen detection technology in North America. The chemiluminescence-based system enables food manufacturers and environmental testing teams to conduct rapid pathogen detection directly on-site for improved contamination control. The partnership includes educational initiatives through NEMIS Academy aimed at transforming food safety standards across the region. NEMIS's technology is already trusted by major European food producers.
  • GradientechminorChannel Partner/ Reseller/ Distributor · 19 February 2025Hardy Diagnostics serves as the exclusive US distribution partner for Gradientech's QuickMIC diagnostic system, which provides rapid antimicrobial susceptibility testing results within 2-4 hours. The system is currently CE marked and used in European hospitals. Gradientech submitted its 510(k) premarket notification to the FDA in late 2025, and FDA clearance would enable Hardy Diagnostics to commercialize the QuickMIC system in the United States.
  • MicrobiologicsminorChannel Partner/ Reseller/ DistributorHardy Diagnostics distributes Microbiologics quality control organisms and molecular controls for use in microbiology laboratories. The partnership provides access to QC microorganisms and reference organisms for laboratory validation and testing procedures.
  • HygienaminorChannel Partner/ Reseller/ DistributorHardy Diagnostics distributes Hygiena ATP monitoring systems including EnSURE luminometers and UltraSnap ATP tests for surface hygiene verification in food safety and environmental monitoring applications.
  • SartoriusminorChannel Partner/ Reseller/ DistributorHardy Diagnostics distributes Sartorius Sterisart sterility testing systems including membrane filtration equipment for pharmaceutical quality control and USP 71 sterility testing compliance.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Hardy Diagnostics competitors and assessment

Company assessment

Direct peers

  • Bio-Rad Laboratories: Bio-Rad is a leading life science and clinical diagnostics manufacturer with a large microbiology product portfolio including culture media, immunoassays, and quality controls, directly competing with Hardy Diagnostics in clinical microbiology labs across the US.
  • bioMérieux: bioMérieux is a global leader in in vitro microbiology diagnostics, including culture media (BioBall, culture plates), VITEK identification/AST systems, and industrial microbiology solutions - directly comparable to Hardy's clinical and pharma microbiology portfolio.
  • Neogen Corporation: Neogen (now merged with 3M's Food Safety business) provides food safety diagnostics, pathogen detection kits, and laboratory products directly comparable to Hardy's food safety testing segment including CompactDry and pathogen detection assays.
  • Eiken Chemical: Eiken Chemical is a Japanese manufacturer specializing in chromogenic culture media, rapid diagnostics, and molecular microbiology products - directly comparable to Hardy's HardyCHROM chromogenic media franchise and compact dry plate lines.

Broad incumbents

  • Becton Dickinson (BD Diagnostic Systems): BD is a broad medical device and diagnostics incumbent with a microbiology portfolio spanning sample collection, plated media, and identification/AST systems, overlapping with Hardy's clinical microbiology offerings as part of a much wider healthcare catalog.
  • Thermo Fisher Scientific (Microbiology): Thermo Fisher operates a massive life sciences catalog including Remel microbiology culture media and diagnostic reagents. It is both a Hardy customer (per disclosed customer list) and a broad incumbent competitor in clinical, food, and pharma microbiology.
  • Beckman Coulter (Danaher): Beckman Coulter, part of Danaher, provides clinical diagnostics including microbiology automation and laboratory information systems, competing with Hardy's clinical lab offerings as part of a much broader diagnostics portfolio.

Emerging players

  • Microbiologics: Microbiologics is a specialty manufacturer of quality control microorganisms, reference strains, and molecular controls for clinical and food labs - a Hardy distribution partner but also a niche competitor in QC organism products.
  • R-Biopharm: R-Biopharm develops and distributes food and clinical pathogen detection kits, lateral flow assays, and laboratory reagents, overlapping with Hardy's food safety and rapid diagnostic offerings particularly across Europe.

Others

  • Hygiena: Hygiena is a manufacturer of ATP hygiene monitoring systems (EnSURE luminometers, UltraSnap tests) - Hardy distributes Hygiena products in the US but Hygiena competes with Hardy's environmental monitoring offerings as part of a broader food safety portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Hardy Diagnostics social profiles

Digital presence

Hardy Diagnostics compliance and trust

Trust signal

Compliance3 records

Hardy Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hardy Diagnostics leadership team

Management profile

Number of profiles

Profiles2 records

Hardy Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hardy Diagnostics M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hardy Diagnostics

What does Hardy Diagnostics do?

Hardy Diagnostics manufactures and distributes microbiological products for clinical, pharmaceutical, food and beverage, cannabis, and cosmetics laboratories. Its portfolio of more than 13,000 laboratory products (over 2,700 manufactured in-house) includes culture media, rapid diagnostic assays, antimicrobial susceptibility disks, specimen collection devices, and laboratory instruments. The company also offers custom product development, contract manufacturing, regulatory submission support, and instrument services.

Is Hardy Diagnostics a public or private company?

Hardy Diagnostics is a private company. It is classified as management employee owned and is currently operating.

When was Hardy Diagnostics founded?

Hardy Diagnostics was founded in 1980. It employs 251 to 500 people.

Where is Hardy Diagnostics based?

Hardy Diagnostics is headquartered in Santa Maria, United States, in the North America region.

How does Hardy Diagnostics make money?

Three revenue lines are on record. Microbiology Products Sales are the primary driver. The others are custom Product Development and distribution Services.

Who are Hardy Diagnostics's main competitors?

Direct peers on record are Bio-Rad Laboratories, bioMérieux, Neogen Corporation and Eiken Chemical. Broad incumbents are Becton Dickinson (BD Diagnostic Systems), Thermo Fisher Scientific (Microbiology) and Beckman Coulter (Danaher). Emerging players are Microbiologics and R-Biopharm. Hygiena is listed as an others.

Does Hardy Diagnostics have an API?

No public API is recorded for Hardy Diagnostics.

What industry is Hardy Diagnostics in?

Hardy Diagnostics's product category is Microbiology Laboratory Products and Diagnostics. Its primary akta.pro industry code is HLAAALAC, Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels), with a secondary code of HLAGADAE, Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireFDA Grants Breakthrough Device Designation to Two Rapid Tests Targeting Critical Drug-Resistant PathogensNG Biotech, in partnership with Hardy Diagnostics, announced that the FDA has granted Breakthrough Device Designations to two rapid diagnostic assays targeting drug-resistant pathogens: NG-TEST® Candida auris and NG-TET® Acineto-5®, both delivering results in 15 minutes. The tests address critical-priority pathogens listed by the WHO and are designed to strengthen surveillance and infection control in healthcare settings. The assays are currently available for Research Use Only while FDA review continues, with Hardy Diagnostics distributing exclusively in the United States.NewswireFDA Grants Breakthrough Device Designation to Two Rapid Tests Targeting Critical Drug-Resistant PathogensNG Biotech, in partnership with Hardy Diagnostics, announced that the U.S. FDA has granted Breakthrough Device Designations to two rapid diagnostic assays: NG-TEST® Candida auris and NG-TEST® Acineto-5®, which target pathogens classified as critical priorities by the WHO. The tests deliver results in 15 minutes without specialized equipment, with the Candida auris test being the first rapid lateral flow immunoassay specifically designed to identify that multidrug-resistant yeast. The assays are developed and manufactured in France by NG Biotech and distributed exclusively in the United States by Hardy Diagnostics, currently available for Research Use Only while FDA review continues.QualityassurancemagHardy Diagnostics Partners with NEMIS Technologies to Bring Rapid On-Site Pathogen Detection to North AmericaHardy Diagnostics announced a partnership with Swiss-based NEMIS Technologies to introduce NEMIS's N-Light rapid on-site pathogen detection technology to the North American market. The chemiluminescence-based technology enables food manufacturers and environmental testing teams to conduct faster contamination detection directly on-site, improving decision-making and proactive food safety monitoring. The collaboration includes educational initiatives through NEMIS Academy and aims to advance food safety standards across the production chain from farm to fork.PR NewswireHardy Diagnostics Partners with NEMIS Technologies to Bring Rapid On-Site Pathogen Detection to North AmericaHardy Diagnostics has announced a strategic partnership with Swiss-based NEMIS Technologies to exclusively distribute NEMIS's N-Light™ rapid on-site pathogen detection technology in North America. The chemiluminescence-based system, already trusted by major European food producers, will enable food manufacturers and environmental testing teams to conduct rapid pathogen detection directly on-site for improved contamination control. The partnership also includes educational initiatives through NEMIS Academy aimed at transforming food safety standards across the region.PR NewswireHardy Diagnostics Announces Retirement of Founder and CEO Jay Hardy; Christopher Catani Named New President and CEOHardy Diagnostics announced the retirement of its founder and CEO Jay Hardy, effective October 13, 2025, after 45 years leading the company he founded in 1980 in Santa Barbara, California. The company's Board of Directors has appointed Christopher Catani, who previously served as CEO for two years and joined the company in 1996, as the new President and CEO effective immediately. Hardy will continue in an advisory role during the transition.news.cision.comGradientech: Interim report January–September 2025Gradientech AB released its Q3 2025 interim report showing net sales of SEK 1,517 thousand (up 83% year-over-year), though the company remained unprofitable with a net loss of SEK -14,990 thousand. Key milestones during the period include securing IVDR certification for the QuickMIC system in the EU, completing the FDA 510(k) clinical study, receiving a significant order from North American distributor Hardy Diagnostics, and raising approximately SEK 60.6 million through a fully subscribed rights issue.PR NewswireNew Rapid Test to Detect CTX-M Enzymes Now FDA-clearedHardy Diagnostics received FDA clearance for NG-TEST CTX-M Multi, a rapid immunoassay detecting CTX-M enzymes from Enterobacterales. The test delivers results in 15 minutes, addressing the growing global threat of ESBL-producing bacteria.YahooNew Rapid Test to Detect CTX-M Enzymes Now FDA-clearedHardy Diagnostics received FDA clearance for NG-TEST CTX-M Multi, a rapid immunoassay detecting CTX-M enzymes from Enterobacterales. The test delivers results in 15 minutes, addressing the growing ESBL resistance threat. Hardy is the exclusive U.S. distributor.PR NewswireHardy Diagnostics announces exclusive partnership for the US and Canada with Gradientech for the commercialization of the QuickMIC® systemHardy Diagnostics has entered into an exclusive partnership with Swedish company Gradientech to distribute the QuickMIC® ultra-rapid antimicrobial susceptibility testing system in the US and Canada. The system, designed to help clinicians make faster antibiotic treatment decisions for sepsis patients, is currently undergoing FDA 510(k) clinical studies at two US hospitals and is already in use at hospitals across Europe. The partnership grants Hardy Diagnostics exclusive distribution rights for this FDA-classified breakthrough device in North America.news.cision.comGradientech welcomes investment from commercial partnerGradientech AB announced an exclusive partnership with Hardy Diagnostics for the commercialization of its QuickMIC® system in the United States and Canada. As part of this agreement, Hardy Diagnostics subscribed to 1,796,571 shares in Gradientech, providing the company with approximately SEK 31.4 million in proceeds.